B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.

Hauser, Stephen L

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. [electronic resource] - The New England journal of medicine Feb 2008 - 676-88 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1533-4406

10.1056/NEJMoa0706383 doi


Adolescent
Adult
Antibodies, Monoclonal--adverse effects
Antibodies, Monoclonal, Murine-Derived
Antigens, CD20
B-Lymphocytes--drug effects
Brain--pathology
Double-Blind Method
Female
Gadolinium
Humans
Immunoglobulins--blood
Immunologic Factors--adverse effects
Infusions, Intravenous
Magnetic Resonance Imaging
Male
Middle Aged
Multiple Sclerosis, Relapsing-Remitting--drug therapy
Remission Induction
Rituximab